Skip to content

Efficacy and safety of extracted Prasaplai for relieving acute muscle strain

Efficacy and safety of extracted Prasaplai for relieving acute muscle strain

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160126001
Enrollment
370
Registered
2016-01-26
Start date
2016-02-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with muscle strain (ICD10 : M5400 &#45

Interventions

Prasaplai extracted capsule 200 mg/cap 2 X 3 ac for 7 days placebo of Diclofenac 25 mg/tab 1 X 3 pc for 7 days,Diclofenac sodium 25 mg/tab 1 X 3 pc for 7 days placebo of Prasaplai 200 mg/cap 2 X
Experimental Drug,Active Comparator Drug
Prasaplai extracted and placebo of diclofenac, Diclofenac and placebo of Prasaplai

Sponsors

Pharmaceutical science, Mahasarakham universitty
Lead Sponsor
Payakkhaphumpisai Hospital&#44
Collaborator
Mahasarakham
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Male or female with aged 20 - 45 years 2. Patient with muscle strain (ICD10 : M5400 - M5409, M6260 - M6269, M7910 - M7919 and M7960 - M7969) who have VAS pain score > 3

Exclusion criteria

Exclusion criteria: 1. Patients with muscle strain cause by infection such as common cold, pyelonephritis. 2. Patients with chronic diseases such as CKD, Cirrhosis or Liver diseases, DM, HT, CVD. 3. Patients with CVD who have to treat by aspirin. 4. Patients who used other drugs such as tramadol, muscle relaxants, corticosteroid, non-steroid anti-inflammatory (NSAIDs) and anti-depressants except paracetamol. 5. Patients who used topical drug including Corticosteroid, non-steroid anti-inflammatory and analgesic prodrugs 6. Patients who are allergic to Prasaplai, Plai and other composition 7. Patients who are allergic to Diclofenac or other NSAIDs or other composition 8. Pregnancy and Lactation

Design outcomes

Primary

MeasureTime frame
Present pain intensity (PPI) 7 days Short- form McGill Pain Questionnaire, Thai version

Secondary

MeasureTime frame
efficacy (VAS, affective score and sensory score) and safety 7 days Short- form McGill Pain Questionnaire (Thai version), ADRs, AEs,proportion of Paracetamol used, satisfaction, Pain relief score, treatment success 7 days Short- form McGill Pain Questionnaire (Thai version)

Countries

Thai

Contacts

Public ContactMatoorada Wisai

Mahasarakham University

doong06@hotmail.com0817688752

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026